drugset / Trial / NCT01617135
Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes
Phase 2
Completed
25 enrolled
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety, efficacy and pharmacokinetics following administration of CVT-301 in treatment of "off" episodes in Parkinson's Disease patients.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-11
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levodopa | Small molecule | — | Inhaled |
| Comparator | Levodopa | Small molecule | — | Oral |